Celltrion celebrates U.S. launch of Zymfentra, offering patients new hope
Celltrion, the pioneering Korean biopharmaceuticals firm, has made a significant stride in the US market with the launch of its groundbreaking autoimmune disease treatment, Zymfentra. [more…]